← Back to headlines
Immunic Secures $400M Financing for Phase 3 MS Data Readout
Immunic has secured $400 million in financing, setting the stage for the readout of its phase 3 multiple sclerosis (MS) data.
26 Feb, 14:02 — 26 Feb, 14:02
ℹOnly 1 source covers this story
